Kimberly-Clark (KMB) Misses Q4 EPS by 5c, Revenue Beats, Offers Guidance

Kimberly-Clark (NYSE: KMB) reported Q4 EPS of $1.60, $0.05 worse than the analyst estimate of $1.65. Revenue for the quarter came in at $4.6 billion versus the consensus estimate of $4.45 billion.

GUIDANCE:

Kimberly-Clark sees FY2019 EPS of $6.50-$6.70, versus the consensus of $6.78.

• Net sales in 2019 are expected to decrease between 1 and 2 percent, including a 3 to 4 percent negative impact from changes in foreign currency exchange rates. Organic sales are expected to increase 2 percent.

For earnings history and earnings-related data on Kimberly-Clark (KMB) click here.

You May Also Be Interested In

• Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
• trivago (TRVG) Misses Q3 EPS by 3c
• Limbach Holdings (LMB) Tops Q3 EPS by 16c, Beats on Revenue; Offers FY26 Revenue Guidance